Company / Current Liabilities per Share
INOVIO PHARMACEUTICALS, INC. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.21
FY2025
5-year range
$0.35 / $2.02
FY2021-FY2025
Trend
-21.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.33 in FY2019 to $2.02 in FY2023.
Based on SEC 10-K filings.
1.21 in FY2025 with a 5-year CAGR of +24.1%.
Improved from $2.02 to $1.21 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +39.5%
- 5-Year CAGR
- +24.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 21.9% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.21 | -21.9% |
| FY2024 | $1.55 | -23.2% |
| FY2023 | $2.02 | +353.0% |
| FY2022 | $0.45 | +26.7% |
| FY2021 | $0.35 | -14.5% |
| FY2020 | $0.41 | +25.1% |
| FY2019 | $0.33 | -15.8% |
| FY2018 | $0.39 | -18.3% |
| FY2017 | $0.48 | -21.2% |
| FY2016 | $0.61 | +17.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026